Windtree Therapeutics Inc (WINT)
0.4961
-0.01
(-2.59%)
USD |
NASDAQ |
Nov 22, 15:06
Windtree Therapeutics Shareholders Equity (Quarterly): 3.494M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 3.494M |
March 31, 2024 | 15.42M |
December 31, 2023 | 3.391M |
September 30, 2023 | 7.484M |
June 30, 2023 | 11.60M |
March 31, 2023 | 7.029M |
December 31, 2022 | 10.01M |
September 30, 2022 | 17.42M |
June 30, 2022 | 19.20M |
March 31, 2022 | 34.73M |
December 31, 2021 | 41.88M |
September 30, 2021 | 50.18M |
June 30, 2021 | 56.76M |
March 31, 2021 | 91.49M |
December 31, 2020 | 69.55M |
September 30, 2020 | 75.72M |
June 30, 2020 | 83.46M |
March 31, 2020 | 70.09M |
December 31, 2019 | 74.94M |
September 30, 2019 | 53.07M |
June 30, 2019 | 58.27M |
March 31, 2019 | 63.00M |
December 31, 2018 | 68.11M |
September 30, 2018 | -31.33M |
June 30, 2018 | -28.38M |
Date | Value |
---|---|
March 31, 2018 | -28.07M |
December 31, 2017 | -23.92M |
September 30, 2017 | -37.45M |
June 30, 2017 | -32.18M |
March 31, 2017 | -25.76M |
December 31, 2016 | -28.83M |
September 30, 2016 | -22.85M |
June 30, 2016 | -15.22M |
March 31, 2016 | -4.977M |
December 31, 2015 | 8.266M |
September 30, 2015 | 17.89M |
June 30, 2015 | -3.078M |
March 31, 2015 | 7.812M |
December 31, 2014 | 19.20M |
September 30, 2014 | 28.96M |
June 30, 2014 | 39.21M |
March 31, 2014 | 48.81M |
December 31, 2013 | 58.50M |
September 30, 2013 | 5.475M |
June 30, 2013 | 16.82M |
March 31, 2013 | 9.457M |
December 31, 2012 | 17.65M |
September 30, 2012 | 23.05M |
June 30, 2012 | 35.70M |
March 31, 2012 | 42.23M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.391M
Minimum
Dec 2023
91.49M
Maximum
Mar 2021
39.15M
Average
34.73M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 430.80M |
AIM ImmunoTech Inc | 2.912M |
Perspective Therapeutics Inc | 328.47M |
Protalix BioTherapeutics Inc | 32.44M |
Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 28.71M |
Total Liabilities (Quarterly) | 25.21M |